61 assets in Cervical Carcinoma

Therapeutic assets addressing Cervical Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
TIL Cervical Carcinoma	City of Hope Medical Center	P1	CC (43)
Tsc-200-A0201 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-201-B0702 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-202-A0201 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-203-A0201 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-A0101 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-A0201 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-C0702 Cervical Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Vudalimab Cervical Carcinoma	Xencor, Inc.	P2	CC (43)
[177lu]lu-akir001 Cervical Carcinoma	Karolinska University Hospital	Early P1	C (39)
Recombinant L-Ifn Adenovirus Cervical Carcinoma	Shanghai Fengxian District Central Hospital	Early P1	C (39)

Showing 51 to 61 of 61 assets

PreviousPage 2 of 2Next